Aarhus University Seal / Aarhus Universitets segl

Main contact for the MiCO Platform project

Mark Denham

Group Leader, Associate Professor

2021.04.29 | MiCO Platform

Novo Nordisk - industry partner in ODIN

Jonathan Niclis from Novo Nordisk is an industry partner MiCO Platform project. He here explains, why the open approach to innovation and collaboration is important.

2021.03.18 | MiCO Platform, BIOMETSCO

omiics - industry partner in ODIN

CEO in omiics, Morten Venø, here explains why it is important for a SMV like omiics to participate in ODIN's open innovation platform.

2021.03.18 | MiCO Platform

Open Collaborations in the MiCO Platform project

Collaboration with industry are key in all ODIN projects. In this video, Mark Denham, lead on the MiCO Platform project, highlights the importance of developing the project proposal together.

2021.02.22 | MiCO Platform

Introducing the MiCO Platform Project

With a starting point in human stem cells, the MiCO Platform team will develop artificial mini-brains, which will provide a more accurate model for human neurological disorders and function as an alternative to the animal models currently used to validate drug candidates. This video introduces the team members and the project aim.

2021.01.28 | People , MiCO Platform

Meet the MiCO Platform team

The team behind the MiCO Platform project aims to develop an alternative to the animal models currently used to validate drug candidates. With a starting point in human stem cells, the team will develop so-called miniaturized controlled organoids (artificial mini-brains), which will provide a more accurate model for human neurological…


Our OPEN approach to innovation in science

In ODIN, all findings and results will be shared openly. 

Researchers working on ODIN projects are encouraged to upload all of their findings to the ODIN community on Zenodo - see the link to the right.

If you have any questions, you are more than welcome to contact the ODIN secretariat.